Liraglutide Injection — Class II drug recall D-0541-2026
Ongoing recall by Lupin Pharmaceuticals Inc., reported 2026-05-27, distributed nationwide. Presence of particulate matter: a white thread-like structure in the cartridge
| Recall number | D-0541-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lupin Pharmaceuticals Inc., Naples, FL, United States |
| Recall initiated | 2026-04-24 |
| Classified | 2026-05-19 |
| Reported by FDA | 2026-05-27 |
| Distributed | Nationwide (US) |
| Quantity | 217,621 pen |
| Reason classes | specification failure |
| NDC | 70748-0346, 70748-0346-02, 70748-0346-03 |
| Expiration dates | 2027-07-20, 2027-10-20, 2027-12-20 |
Product
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.
Reason for recall
Presence of particulate matter: a white thread-like structure in the cartridge
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0541-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.